Evolus, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Evolus, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Evolus, Inc. do? Business model and key facts
Get the full picture of Evolus, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees (FY): 353
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Stocks related to Evolus, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Evolus, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Evolus, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
